Goldman Sachs Reaffirms Buy on SBI Life with 28.8% Upside Prediction

Goldman Sachs has maintained its Buy call on SBI Life Insurance, with a target price of Rs 2,235. This implies about 28.8% upside against the reference price of Rs 1,735.10.

The regulatory overhang on commissions remains, but Goldman acknowledges that SBI Life appears relatively insulated. Management does not expect material disruption to the bancassurance model.

Goldman notes that bancassurance carries structurally lower distribution costs than an agency force because it leverages existing branch networks and customer bases. This insulates insurers like SBI Life from commission rate squeezes, unlike those dependent on independent agents.

Growth guidance for SBI Life remains around 14-15% on individual APE (annualised premium equivalent), with margins supported by mix shift and operating leverage despite GST pressure. Goldman also views protection growth as reflecting genuine demand rather than tax-driven pull-forward.